Document is current
Any future updates will be listed below
-
Authors
Cohen, Nathaniel A.
Steinberg, Joshua M.
Silfen, Alexa
Traboulsi, Cindy
Rodriguez, Tina G.
Singer, Jorie M.
Patel, Shivani
Cohen, Russell D.
Dalal, Sushila R.
Sakuraba, Atsushi
Pekow, Joel
Micic, Dejan
Rubin, David T. https://orcid.org/0000-0001-5647-1723
-
Funding
Funding for this research was provided by:
Goldgrabber Family
- License Information
-
More Information
Article History
Received: 30 July 2022
Accepted: 5 October 2022
First Online: 15 October 2022
Declarations
:
: NAC has served as a consultant for Iterative scopes. DM, AS, CT, TGR, JMS, and AS have no disclosures. JMS was on Advisory Board for Pfizer. SP has served as a consultant for Janssen Biotech and AbbVie. RDC is on the speaker’s bureau from AbbVie and Takeda. He is a consultant/advisor for AbbVie Laboratories, BM/celgene, Eli Lilly, Gilead Sciences, Janssen, Pfizer, Takeda, and UCB Pharma. He has received clinical trial support/grants from Abbvie, BMS/Celgene, Boehringer Ingelheim, Crohn’s and Colitis Foundation of America, Genentech, Gilead Sciences, Hollister, Medimmune, Mesoblast Ltd., Osiris Therpeutics, Pfizer, Receptos, RedHill Biopharma, Sanofi-Aventis, Schwarz Pharma, Seres Therapeutics, Takeda Pharma, and UCB Pharma. His wife is on the board of directors of Aerpio Therapeutics, Novus Therapeutics, Vital Therapeutics Inc., and NantKwest. SRD has served as a consultant for Pfizer and is on the speaker’s bureau for AbbVie. JP has received grant support from AbbVie and Takeda. He has served as a consultant for Veraste, CVS Caremark, and is on the advisory board for Takeda, Janssen, and Pfizer. DTR has received grant support from Takeda and has served as a consultant for Abbvie, Altrubio, Arena Pharmaceuticals, Bristol-Myers Squibb, Genentech/Roche, Gilead Sciences, Iterative Scopes, Janssen Pharmaceuticals, Lilly, Pfizer, Prometheus Biosciences, Takeda, and Techlab Inc.
